News tagged with concurrent chemotherapy


Proton therapy and concurrent chemotherapy may reduce bone marrow toxicity in advanced lung cancer

Medicine & Health / Cancer

created Nov 13, 2008 | popularity 4 / 5 (1) | comments 0

Patients treated for locally advanced non-small cell lung cancer who receive chemotherapy and proton beam therapy have fewer instances of bone marrow toxicity than patients who receive the standard treatment of intensity-modulated ...





Search results for concurrent chemotherapy


Docetaxel given after doxorubicin reduces recurrence

Medicine & Health / Cancer

created Jan 08, 2008 | popularity not rated yet | comments 0

Adding the drug docetaxel to anthracycline-based chemotherapy slightly improved disease-free survival in breast cancer patients, according to a randomized clinical trial published online January 8 in the Journal of the Na ...


High-dose radiation improves lung cancer survival

Medicine & Health / Cancer

created Apr 08, 2009 | popularity 5 / 5 (1) | comments 0

Higher doses of radiation combined with chemotherapy improve survival in patients with stage III lung cancer, according to a new study by researchers at the University of Michigan Comprehensive Cancer Center.


Study finds it's safe to treat HER2-positive breast cancer with trastuzumab and adjuvant radiation

Medicine & Health / Cancer

created Nov 03, 2009 | popularity not rated yet | comments 0

Standard adjuvant treatment for HER2-positive breast cancer patients, following primary surgery for their cancer, is Trastuzumab (Herceptin)--typically used in combination with chemotherapy. However, a new study by researchers ...


Studies show novel device may enhance chemotherapy treatment in brain tumors

Medicine & Health / Cancer

created Nov 24, 2008 | popularity 4.7 / 5 (3) | comments 1

NovoCure Ltd. presented results yesterday evaluating the Novo-TTF device in vitro and in a pilot clinical trial that showed the device enhanced the efficacy of standard chemotherapy (temozolomide) treatment in newly-diagnosed ...


Palliative care intervention provides some benefits for patients with advanced cancer

Medicine & Health / Cancer

created Aug 18, 2009 | popularity not rated yet | comments 0

Patients with advanced cancer who received a palliative care intervention focused on addressing physical and psychosocial issues and care coordination that was provided at the same time as cancer treatment reported improved ...


Long-term testicular cancer survivors at high risk for neurological side effects

Medicine & Health / Cancer

created Nov 25, 2009 | popularity not rated yet | comments 0

Long-term survivors of testicular cancer who were treated with cisplatin-based chemotherapy had more severe side effects, including neurological side effects and Raynaud-like phenomena, than men who were not treated with ...


Considering combination versus sequential chemotherapy in metastatic breast cancer

Medicine & Health / Cancer

created Aug 05, 2009 | popularity not rated yet | comments 0

Both combination and sequential single-agent chemotherapy are reasonable options to treat metastatic breast cancer, but the choice between the two should ultimately be based on patient- and disease-related factors, according ...


Chemotherapy for breast cancer is associated with disruption of sleep-wake rhythm in women

Medicine & Health / Cancer

created Sep 01, 2009 | popularity not rated yet | comments 1

A study in the Sept.1 issue of the journal Sleep shows that the sleep-wake activity rhythms of breast cancer patients are impaired during the administration of chemotherapy. Results indicate that the first cycle of chemot ...


Clinical trial evaluating brain cancer vaccine is underway

Medicine & Health / Cancer

created Oct 19, 2007 | popularity 5 / 5 (3) | comments 0

A clinical trial evaluating a brain cancer vaccine in patients with newly diagnosed brain cancer has begun at NYU Medical Center. The study will evaluate the addition of the vaccine following standard therapy with surgery ...


Adding cetuximab to chemotherapy reduces advanced lung cancer death risk by 13 percent

Medicine & Health / Cancer

created Sep 22, 2009 | popularity not rated yet | comments 0

Patients with advanced non-small cell lung cancer who are given cetuximab (Erbitux) in addition to chemotherapy are 13% less likely to die than those who receive chemotherapy alone, regardless of which chemotherapy drug cocktail ...



List of search results for concurrent chemotherapy